Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Acta Clinica Belgica|August 14, 1998
Late relapse of a non-seminomatous germ cell tumour from residual mature teratomaJ Van den Brande, D Schrijvers, P Vroman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcomaJ Schütte, H T Mouridsen, W Steward, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1983
Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II studyV H Bramwell, H T Mouridsen, J H Mulder, et al.
Lancet (London, England)|May 5, 1979
Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminomaG Stoter, D T Sleijfer, C P Vendrik, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapyJ-Y Blay, M van Glabbeke, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?W Wynendaele, R Derua, M F Hoylaerts, et al.
Breast Cancer Research and Treatment|January 1, 1997
Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinomaP B Vermeulen, M Libura, J Libura, et al.
Journal of Chromatography|December 9, 1983
A gas chromatographic assay for the determination of 5,6-dihydrofluorouracil and 5-fluorouracil in human plasmaE A De Bruijn, O Driessen, N van den Bosch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapyS J Van Belle, M M de Planque, I E Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II clinical trial of doxifluridine in patients with advanced ovarian cancerA T van Oosterom, W W ten Bokkel Huinink, M E van der Burg, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Acta Clinica Belgica|August 14, 1998
Late relapse of a non-seminomatous germ cell tumour from residual mature teratomaJ Van den Brande, D Schrijvers, P Vroman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcomaJ Schütte, H T Mouridsen, W Steward, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1983
Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II studyV H Bramwell, H T Mouridsen, J H Mulder, et al.
Lancet (London, England)|May 5, 1979
Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminomaG Stoter, D T Sleijfer, C P Vendrik, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapyJ-Y Blay, M van Glabbeke, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?W Wynendaele, R Derua, M F Hoylaerts, et al.
Breast Cancer Research and Treatment|January 1, 1997
Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinomaP B Vermeulen, M Libura, J Libura, et al.
Journal of Chromatography|December 9, 1983
A gas chromatographic assay for the determination of 5,6-dihydrofluorouracil and 5-fluorouracil in human plasmaE A De Bruijn, O Driessen, N van den Bosch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapyS J Van Belle, M M de Planque, I E Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II clinical trial of doxifluridine in patients with advanced ovarian cancerA T van Oosterom, W W ten Bokkel Huinink, M E van der Burg, et al.
Pageof 20